<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03942549</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00019197</org_study_id>
    <nct_id>NCT03942549</nct_id>
  </id_info>
  <brief_title>Changes in the Bladder Micro-environment Following Midurethral Sling Surgery for Stress Urinary Incontinence</brief_title>
  <official_title>Changes in the Bladder Micro-environment Following Midurethral Sling Surgery for Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Collins Medical Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational cohort study is aimed at determining changes in the cytokine expression&#xD;
      profile as well as the urinary and vaginal microbiome of women undergoing midurethral sling&#xD;
      placement for the treatment of stress urinary incontinence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objectives:&#xD;
&#xD;
      This is a pilot study to evaluate how midurethral sling (MUS) placement for the treatment of&#xD;
      stress urinary incontinence (SUI) affects the bladder microenvironment, specifically the&#xD;
      local microbial community or &quot;microbiome&quot; of the bladder and the cytokine expression profile.&#xD;
      The investigators also aim to correlate any changes in the microbiome or cytokine expression&#xD;
      profile with patient-reported urinary symptoms preoperatively and postoperatively.&#xD;
&#xD;
      Specific Aim 1: Assess the change in the urinary and vaginal microbiome (preoperatively to&#xD;
      postoperatively) in women undergoing MUS placement for the treatment of SUI. The&#xD;
      investigators hypothesize that the bladder environment will be disturbed by surgery involving&#xD;
      the lower urinary tract and will show demonstrable changes in the urinary and vaginal&#xD;
      microbiota.&#xD;
&#xD;
      Specific Aim 2: Characterize the cytokine profile of the bladder (preoperatively to&#xD;
      postoperatively) in women undergoing MUS placement for the treatment of SUI. The&#xD;
      investigators hypothesize that MUS treatment will change the cytokine profile of the bladder&#xD;
      and lead to alterations in the expression of pro-inflammatory cytokines.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 3, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Weeks</target_duration>
  <primary_outcome>
    <measure>Urinary Microbiome</measure>
    <time_frame>Six weeks</time_frame>
    <description>change in the relative abundance of urinary lactobacillus between baseline, 2 and 6 weeks postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of overactive bladder symptoms</measure>
    <time_frame>Six weeks</time_frame>
    <description>Validated symptom questionnaires will be collected at baseline and again at 2 and six weeks postoperatively to assess common symptoms associated with overactive bladder.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>MUS Cohort</arm_group_label>
    <description>This cohort will undergo midurethral sling placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Retropubic midurethral sling</intervention_name>
    <description>Midurethral sling</description>
    <arm_group_label>MUS Cohort</arm_group_label>
    <other_name>TVT</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will include women over the age of 18 planning to undergo stand-alone&#xD;
        midurethral sling placement for treatment of stress urinary incontinence.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years old&#xD;
&#xD;
          -  Planning to undergo retropubic midurethral sling placement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior surgery for stress urinary incontinence&#xD;
&#xD;
          -  Untreated pelvic organ prolapse &gt; Stage II based on POP-Q assessment&#xD;
&#xD;
          -  Concomitant surgery for prolapse&#xD;
&#xD;
          -  Current use of anticholinergic medications&#xD;
&#xD;
          -  Use of systemic or vaginal antibiotics in the last 2 months&#xD;
&#xD;
          -  Active urinary tract infection&#xD;
&#xD;
          -  History of recurrent UTI&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of pelvic radiation or bladder cancer&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Legacy Good Samaritan Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 3, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Ian Fields</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>microbiome</keyword>
  <keyword>cytokine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

